Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
NVST

NVST - Envista Holdings Corp Stock Price, Fair Value and News

$24.61-0.83 (-3.26%)
Delayed

50/100

NVST

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

50/100

NVST

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

NVST Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NVST Price Action

Last 7 days

-8.4%

Last 30 days

-18.7%

Last 90 days

12.0%

Trailing 12 Months

51.5%

NVST RSI Chart

NVST Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NVST Valuation

Market Cap

4.0B

Price/Earnings (Trailing)

85.81

Price/Sales (Trailing)

1.48

EV/EBITDA

16.2

Price/Free Cashflow

17.5

NVST Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

NVST Fundamentals

NVST Revenue

Revenue (TTM)

2.7B

Rev. Growth (Yr)

14.96%

Rev. Growth (Qtr)

12.05%

NVST Earnings

Earnings (TTM)

47.0M

Earnings Growth (Yr)

2.6K%

Earnings Growth (Qtr)

208.58%

NVST Profitability

EBT Margin

6.52%

Return on Equity

1.51%

Return on Assets

0.83%

Free Cashflow Yield

5.71%

NVST Investor Care

Buy Backs (1Y)

4.83%

Diluted EPS (TTM)

0.28

NVST Alerts

  • 1 major insider sales recently.
  • Big jump in Earnings (Y/Y)

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20252.5B2.6B2.6B2.7B
20242.6B2.5B2.5B2.5B
20232.6B2.6B2.6B2.6B
20222.5B2.5B2.6B2.6B
20212.1B2.4B2.5B2.5B
20202.5B2.1B2.0B1.9B
20192.8B2.8B2.8B2.8B
20182.8B2.8B2.8B2.8B
20170002.8B
20160002.8B
Get all data in R, Python etc through our Historical Stock Data APIs

About Envista Holdings Corp

NVST
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant for treatment planning of dental implants; DTX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic, a software package offered with its imaging devices. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
 CEO
 WEBSITEhttps://envistaco.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES12700

Envista Holdings Corp Frequently Asked Questions

NVST is the stock ticker symbol of Envista Holdings Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of Envista Holdings Corp is 4.03 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, NVST's PE ratio (Price to Earnings) is 85.81 and Price to Sales (PS) ratio is 1.48. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NVST PE ratio will change depending on the future growth rate expectations of investors.